메뉴 건너뛰기




Volumn 33, Issue 6, 1998, Pages 521-533

Focus on naratriptan: An oral 5-HT1 receptor agonist for acute treatment of migraine

(2)  Reddy, Prabashni a   Lee, Nora a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NARATRIPTAN; SEROTONIN 1 AGONIST; SUMATRIPTAN SUCCINATE;

EID: 0032457092     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (4)

References (15)
  • 2
    • 0030905949 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and management of migraine in clinical practice
    • Pryse-Phillips WEM, Dodick DW, Edmeads JG, et al. Guidelines for the diagnosis and management of migraine in clinical practice. Can Med Assoc J 1997; 156:1273-87.
    • (1997) Can Med Assoc J , vol.156 , pp. 1273-1287
    • Pryse-Phillips, W.E.M.1    Dodick, D.W.2    Edmeads, J.G.3
  • 3
    • 0030614987 scopus 로고    scopus 로고
    • 1D) agonists and other agents in acute migraine
    • 1D) agonists and other agents in acute migraine. Neurol Clin 1997;15:61-83.
    • (1997) Neurol Clin , vol.15 , pp. 61-83
    • Mathew, N.T.1
  • 5
    • 0032481904 scopus 로고    scopus 로고
    • Migraine
    • Ferrari MD. Migraine. Lancet 1998;351:1043-51.
    • (1998) Lancet , vol.351 , pp. 1043-1051
    • Ferrari, M.D.1
  • 7
    • 0001654075 scopus 로고    scopus 로고
    • A study to determine the absolute oral bioavailability of naratriptan
    • Abstract 07-A 15
    • Fuseau E, Baille P, Kempsford RD, et al. A study to determine the absolute oral bioavailability of naratriptan. Cephalalgia 1997;17:417. Abstract 07-A 15.
    • (1997) Cephalalgia , vol.17 , pp. 417
    • Fuseau, E.1    Baille, P.2    Kempsford, R.D.3
  • 9
    • 0030908742 scopus 로고    scopus 로고
    • Naratriptan: Biological profile in animal models relevant to migraine
    • Connor HE, Feniuk W, Beanie DT, et al. Naratriptan: Biological profile in animal models relevant to migraine. Cephalalgia 1997;17:145-52.
    • (1997) Cephalalgia , vol.17 , pp. 145-152
    • Connor, H.E.1    Feniuk, W.2    Beanie, D.T.3
  • 11
    • 0344865854 scopus 로고    scopus 로고
    • A study of the effect of subcutaneous naratriptan 1.5 mg on myocardial perfusion in migraineurs using positron emission tomography
    • Abstract 07-A 37
    • Camici P, Melin J, Gnecchi-Ruscone T, et al. A study of the effect of subcutaneous naratriptan 1.5 mg on myocardial perfusion in migraineurs using positron emission tomography. Cephalalgia 1997;17:424. Abstract 07-A 37.
    • (1997) Cephalalgia , vol.17 , pp. 424
    • Camici, P.1    Melin, J.2    Gnecchi-Ruscone, T.3
  • 12
    • 0343103886 scopus 로고    scopus 로고
    • The effects of subcutaneous naratriptan 1.5 mg on the systemic, pulmonary, and coronary circulation in patients with suspected coronary artery disease
    • Abstract 07-A 47
    • Swan L, Birnie DH, Hood S, et al. The effects of subcutaneous naratriptan 1.5 mg on the systemic, pulmonary, and coronary circulation in patients with suspected coronary artery disease. Cephalalgia 1997;17:428. Abstract 07-A 47.
    • (1997) Cephalalgia , vol.17 , pp. 428
    • Swan, L.1    Birnie, D.H.2    Hood, S.3
  • 13
    • 9844243943 scopus 로고    scopus 로고
    • Subcutaneous naratriptan (1 mg, 5 mg and 10 mg) has no effect on peripheral blood flow as measured by forearm blood flow
    • Abstract 07-A 40
    • Yogendran L, Boswell D, Winter P, et al. Subcutaneous naratriptan (1 mg, 5 mg and 10 mg) has no effect on peripheral blood flow as measured by forearm blood flow. Cephalalgia 1997;17:425. Abstract 07-A 40.
    • (1997) Cephalalgia , vol.17 , pp. 425
    • Yogendran, L.1    Boswell, D.2    Winter, P.3
  • 14
    • 0002198120 scopus 로고    scopus 로고
    • The safety, tolerability, pharmacodynamics and pharmacokinetics of naratriptan in healthy elderly subjects
    • Abstract 3-21-04
    • Kempsford R, Fuseau E, Moss J, Bryson P. The safety, tolerability, pharmacodynamics and pharmacokinetics of naratriptan in healthy elderly subjects. J Neurol Sci 1997;150(Suppl):S168. Abstract 3-21-04.
    • (1997) J Neurol Sci , vol.150 , Issue.SUPPL.
    • Kempsford, R.1    Fuseau, E.2    Moss, J.3    Bryson, P.4
  • 15
    • 0002198120 scopus 로고    scopus 로고
    • Naratriptan oral pharmacokinetics in migraine subjects
    • Abstract 1-21-09
    • Fuseau E, Webster C, Asgharnejad M, Huffman C. Naratriptan oral pharmacokinetics in migraine subjects. J Neurol Sci 1997;150(Suppl):S33. Abstract 1-21-09.
    • (1997) J Neurol Sci , vol.150 , Issue.SUPPL.
    • Fuseau, E.1    Webster, C.2    Asgharnejad, M.3    Huffman, C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.